Design Therapeutics's total assets for Q1 2025 were $237.47M, a decrease of -5.80% from the previous quarter. DSGN total liabilities were $9.56M for the fiscal quarter, a -4.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.